Lots of short squeezing taking place in biotech, with SRPT leading the fray thanks to positive clinical data. Other DMD related biotechs are scorching higher in kind, namely SLDB. I have no edge here, so I don’t even bother.
The other one that caught my eye is GEVO. I had a buy order in when it was $16.5, but chickened out. Now look at the fucker, encroaching on $24. Imagine being short from $2? Margin clerks must be freaking out.
Other than that, there really isn’t much to buy. Lots of SAAS stocks are getting murderhole’d — like SMAR. The way I see it, now is a good time to eat a large roasted beef sandwich, enjoy the comforts of cash, and wait for clarity.
Lots of old man stocks and utilities are higher — due to defensiveFAGS piling in. I have no interest in that game. Too slow and boring, and also slow.If you enjoy the content at iBankCoin, please follow us on Twitter